Critical

ARDS / refractory hypoxaemia

Refractory hypoxaemia · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

ARDS is acute diffuse inflammatory lung injury causing increased-permeability (non-cardiogenic) pulmonary oedema and refractory hypoxaemia. The BERLIN definition requires all of: onset within 1 WEEK of a known insult, BILATERAL opacities on imaging not fully explained by effusions/collapse, respiratory failure NOT fully explained by cardiac failure or fluid overload, and a PaO₂/FiO₂ ratio ≤ 300 on PEEP/CPAP ≥ 5 cmH₂O — graded MILD (200–300), MODERATE (100–200) or SEVERE (< 100). The pathology is DIFFUSE ALVEOLAR DAMAGE evolving through an EXUDATIVE phase (oedema, hyaline membranes, ~first week), a PROLIFERATIVE phase, and sometimes a FIBROTIC phase.

Assessment

Differential diagnosis

  • Cardiogenic pulmonary oedema / fluid overload (the key distinction)
  • Diffuse alveolar haemorrhage
  • Acute interstitial pneumonia / acute eosinophilic pneumonia
  • Bilateral pneumonia; TRALI (transfusion-related)

Investigations

  • Calculate the PaO₂/FiO₂ ratio on PEEP ≥ 5 and grade severity (Berlin)
  • Chest X-ray/CT — bilateral opacities; echocardiography if needed to exclude a primarily cardiac cause
  • Identify the PRECIPITANT and screen for sepsis (cultures, etc.)
  • Bloods/gas, and consider the cause-specific work-up (amylase, autoimmune, etc.)

Complications & pitfalls

  • Refractory hypoxaemia and multi-organ failure
  • Ventilator-induced lung injury (barotrauma/pneumothorax)
  • Pulmonary fibrosis; nosocomial infection; VTE
  • High mortality — rises with severity

Exam pearls

  • Diagnose ARDS by the BERLIN criteria — acute (≤ 1 week), bilateral opacities, not cardiac/overload, and PaO₂/FiO₂ ≤ 300 on PEEP ≥ 5.
  • The pathology is diffuse alveolar damage — a permeability oedema, NOT a volume/cardiac problem.
  • Causes are DIRECT lung injury (pneumonia, aspiration, inhalation, contusion, near-drowning) or INDIRECT (SEPSIS — the commonest, pancreatitis, massive transfusion/TRALI, trauma, burns).
  • Grade severity (mild/moderate/severe) — it drives management intensity (lung-protective ventilation, proning, etc.) and predicts outcome.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.